FindTrial
Sign In

Natural orifice transluminal endoscopic debridement in the treatment of severe acute pancreatitis with infected pancreatic necrosis and pancreatic abscess

Natural orifice transluminal endoscopic debridement in the treatment of severe acute pancreatitis with infected pancreatic necrosis and pancreatic abscess

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-13003653
Enrollment
Unknown
Registered
2013-02-05
Start date
2013-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe acute pancreatitis

Interventions

A:endoscopic necrosectomy and drainage
B:percutaneous catheter drainage

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 70 years old; 2) meet the diagnostic criteria of acute pancreatitis; 3) there is extraluminal gas in the pancreatic and/or peripancreatictissues on CECT or fine-needle aspiration (FNA) is positive for bacteriaand/or fungi on Gram stain and culture

Exclusion criteria

Exclusion criteria: 1) A serious heart, lung, liver disease, blood coagulation dysfunction and other endoscopic contraindications. 2) pregnant or lactating women; 3) refused to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
recovery rate;Transfer rate of surgery;—

Secondary

MeasureTime frame
The incidence of complications;mortality;Length of hospital stay;hospital expense;—

Countries

China

Contacts

Public ContactYong Zhu

The First Affiliated Hospital of Nanchang University

zyblack@163.com+86 79188692505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 10, 2026